• Tumor-Infiltrating Lymphocyte (TIL) Therapy

  • Aug 29 2024
  • Duración: 19 m
  • Podcast

Tumor-Infiltrating Lymphocyte (TIL) Therapy

  • Resumen

  • Thach-Giao Truong, MD, Director of the Melanoma Program at Cleveland Clinic, joins the Cancer Advances podcast to discuss Tumor-Infiltrating Lymphocyte (TIL) therapy. This cutting-edge, personalized cancer treatment utilizes a patient's immune cells to target and destroy tumors. Listen as Dr. Truong provides insights into the science behind TIL therapy, its advantages, and its potential to revolutionize treatment for patients with resistant melanoma and other challenging cancers.

    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre Tumor-Infiltrating Lymphocyte (TIL) Therapy

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.